MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcdd10090386

Медицинская библиотека · Journal of cardiovascular development and disease · 2023

Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice.

Zhou Yangzhao, Yuan Zhaoshun, Wang Min, Zhang Zhiyuan, Tan Changming, Yu Jiaolian, Bi Yanfeng, Liao Xiaobo, Zhou Xinmin, Ali Sheikh Md Sayed, Yang Dafeng

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Calcific aortic valve disease (CAVD) is a significant cause of morbidity and mortality among elderly people. However, no effective medications have been approved to slow or prevent the progression of CAVD. Here, we examined the effect of liraglutide on aortic valve stenosis.

METHODS

Male Apoe-/- mice were fed with a high-cholesterol diet for 24 weeks to generate an experimental CAVD model and randomly assigned to a liraglutide treatment group or control group. Echocardiography and immunohistological analyses were performed to examine the aortic valve function and morphology, fibrosis, and calcium deposition. Plasma Glucagon-like peptide-1 (GLP-1) levels and inflammatory contents were measured via ELISA, FACS, and immunofluorescence. RNA sequencing (RNA-seq) was used to identify liraglutide-affected pathways and processes.

RESULTS

Plasma GLP-1 levels were reduced in the CAVD model, and liraglutide treatment significantly improved aortic valve calcification and functions and attenuated inflammation. RNA-seq showed that liraglutide affects multiple myofibroblastic and osteogenic differentiations or inflammation-associated biological states or processes in the aortic valve. Those liraglutide-mediated beneficial effects were associated with increased GLP-1 receptor (GLP-1R) expression.

CONCLUSIONS

Liraglutide blocks aortic valve calcification and may serve as a potential therapeutic drug for CAVD treatment.

Для цитирования: Zhou Yangzhao, Yuan Zhaoshun, Wang Min, Zhang Zhiyuan, Tan Changming, Yu Jiaolian, Bi Yanfeng, Liao Xiaobo, Zhou Xinmin, Ali Sheikh Md Sayed, Yang Dafeng. Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice.. Journal of cardiovascular development and disease. 2023. DOI: 10.3390/jcdd10090386.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.